CL2015002725A1 - Compuestos aromáticos sustituidos para el tratamiento de la fibrosis pulmonar, la fibrosis hepática, la fibrosis de la piel y la fibrosis cardíaca - Google Patents
Compuestos aromáticos sustituidos para el tratamiento de la fibrosis pulmonar, la fibrosis hepática, la fibrosis de la piel y la fibrosis cardíacaInfo
- Publication number
- CL2015002725A1 CL2015002725A1 CL2015002725A CL2015002725A CL2015002725A1 CL 2015002725 A1 CL2015002725 A1 CL 2015002725A1 CL 2015002725 A CL2015002725 A CL 2015002725A CL 2015002725 A CL2015002725 A CL 2015002725A CL 2015002725 A1 CL2015002725 A1 CL 2015002725A1
- Authority
- CL
- Chile
- Prior art keywords
- fibrosis
- skin
- treatment
- pulmonary
- aromatic compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
- C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
COMPUESTOS FENIL SUSTITUIDOS; KIT; METODO PARA PREVENIR Y/O RALENTIZAR EL AVANCE Y/O TRATAR ENFERMEDADES FIBROTICAS TALES COMO FIBROSIS PULMONAR, HEPATICA, DE LA PIEL O CARDIACA; METODO PARA ANTAGONIZAR LA SECRECION DE COLAGENO O SU DEPOSITO EN UN ORGANO; Y METODO PARA REDUCIR LA PRODUCCION DE COLAGENO EN LAS CELULAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361798427P | 2013-03-15 | 2013-03-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2015002725A1 true CL2015002725A1 (es) | 2016-04-15 |
Family
ID=51535670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2015002725A CL2015002725A1 (es) | 2013-03-15 | 2015-09-15 | Compuestos aromáticos sustituidos para el tratamiento de la fibrosis pulmonar, la fibrosis hepática, la fibrosis de la piel y la fibrosis cardíaca |
Country Status (26)
Country | Link |
---|---|
US (3) | US9884802B2 (es) |
EP (1) | EP2970088B1 (es) |
JP (1) | JP6381557B2 (es) |
KR (1) | KR102303493B1 (es) |
CN (1) | CN105143170B (es) |
AR (1) | AR095427A1 (es) |
AU (1) | AU2014231649C1 (es) |
BR (1) | BR112015023129A2 (es) |
CA (1) | CA2905633C (es) |
CL (1) | CL2015002725A1 (es) |
DK (1) | DK2970088T3 (es) |
EA (1) | EA031511B1 (es) |
ES (1) | ES2780825T3 (es) |
HK (1) | HK1220439A1 (es) |
IL (1) | IL241164B (es) |
MX (1) | MX2015012886A (es) |
MY (1) | MY194727A (es) |
NZ (1) | NZ712745A (es) |
PH (1) | PH12015502012A1 (es) |
PL (1) | PL2970088T3 (es) |
PT (1) | PT2970088T (es) |
SG (1) | SG11201507274PA (es) |
TW (2) | TWI742541B (es) |
UY (1) | UY35401A (es) |
WO (1) | WO2014138907A1 (es) |
ZA (1) | ZA201507062B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014110574A1 (en) | 2013-01-14 | 2014-07-17 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors |
SG10201705662WA (en) | 2013-01-15 | 2017-08-30 | Incyte Corp | Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors |
TWI742541B (zh) * | 2013-03-15 | 2021-10-11 | 英商邊緣生物科技有限公司 | 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物 |
PE20160532A1 (es) | 2013-08-23 | 2016-05-21 | Incyte Corp | Compuesto de carboxamida de furo y tienopiridina utiles como inhibidores de cinasas pim |
US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
WO2016010897A1 (en) | 2014-07-14 | 2016-01-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors |
RU2709205C2 (ru) * | 2014-10-10 | 2019-12-17 | Прометик Фарма Смт Лимитед | Замещенные ароматические соединения и фармацевтические композиции для предотвращения и лечения остеопороза |
RU2728782C2 (ru) | 2014-11-12 | 2020-07-31 | Лиминал Байосайенсиз Лимитед | Замещенные ароматические соединения и фармацевтические композиции для ауторепарации и регенерации ткани |
MA41120A (fr) * | 2014-12-02 | 2017-10-10 | Afimmune Ltd | Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci |
WO2016196244A1 (en) | 2015-05-29 | 2016-12-08 | Incyte Corporation | Pyridineamine compounds useful as pim kinase inhibitors |
US10046007B2 (en) * | 2015-06-24 | 2018-08-14 | Prescient Pharma, Llc | Compositions and methods for treatment of short telomere disorders |
TWI734699B (zh) | 2015-09-09 | 2021-08-01 | 美商英塞特公司 | Pim激酶抑制劑之鹽 |
TW201718546A (zh) | 2015-10-02 | 2017-06-01 | 英塞特公司 | 適用作pim激酶抑制劑之雜環化合物 |
IL243707A0 (en) | 2016-01-20 | 2016-05-01 | Galmed Res And Dev Ltd | Treatment to regulate the microbiota in the intestine |
US11197870B2 (en) | 2016-11-10 | 2021-12-14 | Galmed Research And Development Ltd | Treatment for hepatic fibrosis |
SG11202004408YA (en) * | 2017-11-15 | 2020-06-29 | Galapagos Nv | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
US10596161B2 (en) | 2017-12-08 | 2020-03-24 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
JP2022510436A (ja) * | 2018-12-05 | 2022-01-26 | リミナル・バイオサイエンシーズ・リミテッド | アルストレーム症候群の治療における2-(3-ペンチルフェニル)酢酸ナトリウムの使用 |
WO2020181163A1 (en) * | 2019-03-06 | 2020-09-10 | Tobira Therapeutics, Inc. | Lipid-based formulation of cenicriviroc |
WO2021015218A1 (ja) * | 2019-07-24 | 2021-01-28 | 国立大学法人九州大学 | 転写関連因子を標的とする線維化疾患の予防または治療 |
CN112441916A (zh) * | 2019-08-29 | 2021-03-05 | 广东药科大学 | 新型苯乙酸衍生物、其制备方法及其作为药物的用途 |
US20220193073A1 (en) * | 2020-12-18 | 2022-06-23 | NovMeta Pharma Co., Ltd. | Method of treating fibrosis |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20012434A1 (it) | 2001-11-20 | 2003-05-20 | Dompe Spa | Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono |
JP5844251B2 (ja) * | 2009-05-04 | 2016-01-13 | プロメティック・バイオサイエンシーズ・インコーポレイテッドProMetic BioSciences Inc. | 3−ペンチルフェニル酢酸の塩およびその薬学的使用 |
SG175855A1 (en) * | 2009-05-04 | 2011-12-29 | Prometic Biosciences Inc | Substituted aromatic compounds and pharmaceutical uses thereof |
PL3443957T3 (pl) * | 2010-10-27 | 2021-05-04 | Liminal Biosciences Limited | Związki i kompozycje stosowane w leczeniu nowotworów |
CN102070433B (zh) * | 2010-12-27 | 2013-03-27 | 桂林师范高等专科学校 | 芳香基乙酸类衍生物的制备方法 |
TWI689490B (zh) * | 2013-03-15 | 2020-04-01 | 英商邊緣生物科技有限公司 | 用於治療纖維化之經取代之芳族化合物及相關方法 |
TWI742541B (zh) * | 2013-03-15 | 2021-10-11 | 英商邊緣生物科技有限公司 | 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物 |
RU2728782C2 (ru) * | 2014-11-12 | 2020-07-31 | Лиминал Байосайенсиз Лимитед | Замещенные ароматические соединения и фармацевтические композиции для ауторепарации и регенерации ткани |
-
2014
- 2014-03-12 TW TW109106077A patent/TWI742541B/zh active
- 2014-03-12 TW TW103108714A patent/TWI689489B/zh not_active IP Right Cessation
- 2014-03-13 UY UY0001035401A patent/UY35401A/es not_active Application Discontinuation
- 2014-03-13 AR ARP140100971A patent/AR095427A1/es unknown
- 2014-03-14 EA EA201591774A patent/EA031511B1/ru not_active IP Right Cessation
- 2014-03-14 EP EP14762607.1A patent/EP2970088B1/en active Active
- 2014-03-14 CA CA2905633A patent/CA2905633C/en active Active
- 2014-03-14 ES ES14762607T patent/ES2780825T3/es active Active
- 2014-03-14 JP JP2015561850A patent/JP6381557B2/ja not_active Expired - Fee Related
- 2014-03-14 CN CN201480015002.6A patent/CN105143170B/zh not_active Expired - Fee Related
- 2014-03-14 US US14/775,882 patent/US9884802B2/en active Active
- 2014-03-14 DK DK14762607.1T patent/DK2970088T3/da active
- 2014-03-14 KR KR1020157029285A patent/KR102303493B1/ko active IP Right Grant
- 2014-03-14 WO PCT/CA2014/000237 patent/WO2014138907A1/en active Application Filing
- 2014-03-14 MX MX2015012886A patent/MX2015012886A/es active IP Right Grant
- 2014-03-14 BR BR112015023129A patent/BR112015023129A2/pt not_active Application Discontinuation
- 2014-03-14 PT PT147626071T patent/PT2970088T/pt unknown
- 2014-03-14 MY MYPI2015002292A patent/MY194727A/en unknown
- 2014-03-14 PL PL14762607T patent/PL2970088T3/pl unknown
- 2014-03-14 SG SG11201507274PA patent/SG11201507274PA/en unknown
- 2014-03-14 NZ NZ712745A patent/NZ712745A/en not_active IP Right Cessation
- 2014-03-14 AU AU2014231649A patent/AU2014231649C1/en not_active Ceased
-
2015
- 2015-09-03 IL IL241164A patent/IL241164B/en active IP Right Grant
- 2015-09-09 PH PH12015502012A patent/PH12015502012A1/en unknown
- 2015-09-15 CL CL2015002725A patent/CL2015002725A1/es unknown
- 2015-09-22 ZA ZA2015/07062A patent/ZA201507062B/en unknown
-
2016
- 2016-07-15 HK HK16108375.0A patent/HK1220439A1/zh unknown
-
2017
- 2017-12-22 US US15/852,977 patent/US10450258B2/en not_active Expired - Fee Related
-
2019
- 2019-09-24 US US16/580,747 patent/US11267779B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2015002725A1 (es) | Compuestos aromáticos sustituidos para el tratamiento de la fibrosis pulmonar, la fibrosis hepática, la fibrosis de la piel y la fibrosis cardíaca | |
HK1252351A1 (zh) | 經修飾的因子ix、以及用於基因轉移到細胞、器官和組織的組合物、方法和用途 | |
EP3269378A4 (en) | Composition for preventing or treating inflammatory diseases, comprising lactic acid bacteria-derived extracellular vesicles as active ingredients | |
MX2021009673A (es) | Moduladores de ror-gamma. | |
EP3473726B8 (en) | Fermentation technique to improve production level of recombinant human collagen | |
CL2015002535A1 (es) | Compuestos aromáticos sustituidos y método relacionado para el tratamiento de la fibrosis | |
BR112017011923A2 (pt) | bactéria modificada para tratar doenças associadas com hiperamonemia | |
BR112017024384A2 (pt) | bactérias modificadas para reduzir hiperfenilalaninemia | |
EP4282479A3 (en) | Use of pridopidine to treat depression or anxiety | |
MX2021007268A (es) | Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas. | |
ECSP13012978A (es) | Inhibidores de glucosilceramida sintasa | |
BR112013027307A2 (pt) | método para tratar uma matriz de tecido; matriz de tecido acelular | |
WO2015075557A3 (en) | C/ebp alpha short activating rna compositions and methods of use | |
WO2014179564A8 (en) | Thiazolopyrrolidine inhibitors of ror-gamma | |
EP4299122A3 (en) | Compositions and methods for treating skin and mucous membrane diseases | |
EA201692292A1 (ru) | Соединения и композиции для стимулирования хондрогенеза | |
MX2015016100A (es) | Inhibidores de criopirina para prevenir y tratar la inflamacion. | |
ZA201904522B (en) | Heterocyclic inhibitors of mct4 | |
MX2017002765A (es) | Il-23a y tnf-alfa orientados y compuesto y sus usos. | |
CL2016000436A1 (es) | Método para el tratamiento de la enfermedad fibrótica | |
EA201600096A1 (ru) | Бензил-1н-пиразол[3,4-b]пиридины и их применение | |
PT3551748T (pt) | Células estaminais do mesênquima derivadas de tecido perinatal: método de preparação e suas utilizações | |
EP3123860A4 (en) | Acellular collagenous tissue and processing method of artificial valve comprising acellular collagenous tissue | |
TW201613949A (en) | Targeting microRNAs for metabolic disorders | |
EA201592073A1 (ru) | Фармацевтические композиции, содержащие коллаген и гиалуронат натрия |